Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million
Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million…
Lucid Diligence Brief: Altesa BioSciences $75 million Series B for vapendavir in COPD
Lucid Diligence Brief: Altesa BioSciences $75 million Series B for vapendavir…
Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal
Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal…
Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA biomarkers
Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA…
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home Alzheimer’s blood collection
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home…
Lucid Diligence Brief: Abbott to acquire Exact Sciences
Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG Professional…
Oncology Weekly News - September 22nd 2025
Oncology Update: RGT-61159 Orphan Drug, CRB-701 Fast Track, PDS0101 Survival…
ELCC 2025 Preview: Key Lung Cancer Highlights to Watch
ELCC 2025 at a glance Looking toward ELCC 2025, LucidQuest highlights…